ONA Therapeutics

SME

ONA Therapeutics

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

ONA Therapeutics

Address

Barcelona, Catalunya, Spain

Contact

info@ona-therapeutics.com

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with ONA Therapeutics

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

ONA Therapeutics last news

18/12/2023

Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors

Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors Beijing, China and Barcelona, Spain, December 18th, 2023 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ('Biocytogen', HKEX: 02315), a global biotech company focusing on the discovery and development of novel antibody therapeutics, today announces an antibody evaluation, option and [...] The post Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors appeared first on Ona Therapeutics .

23/05/2023

ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors

Leading medical oncologist and seasoned biotechnology executive with significant experience in drug development Barcelona, Spain, 23 May 2023: ONA Therapeutics ("ONA"), which is specialized in unravelling novel biology to design biopharmaceuticals attacking advanced cancer, is pleased to announce the appointment of Dr. Pamela Klein as independent member to its board of directors. Dr. [...] The post ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors appeared first on Ona Therapeutics .

21/10/2022

Premio Nacional de Innovación en el IRB Barcelona por la creación de Ona Therapeutics

Premio Nacional de Innovación en el IRB Barcelona por la creación de Ona Therapeutics   LEER LA NOTÍCIA The post Premio Nacional de Innovación en el IRB Barcelona por la creación de Ona Therapeutics appeared first on Ona Therapeutics .